Literature DB >> 17975474

Molecular mechanisms of increased intrahepatic resistance in portal hypertension.

Vijay Shah1.   

Abstract

Portal hypertension is associated with changes in the intrahepatic, systemic, and portosystemic collateral circulation. Alterations in vasoreactivity (vasodilation and vasoconstriction) play a central role in the pathogenesis of portal hypertension by contributing to increased intrahepatic resistance, hyperdynamic circulation, and expansion of the collateral circulation. Portal hypertension is also importantly characterized by changes in vascular structure; termed vascular remodeling, which is an adaptive response of the vessel wall that occurs in response to chronic changes in the environment such as shear stress. These complementary processes of vasoreactivity and vascular remodeling contribute importantly to increased intrahepatic resistance and represent important targets in the treatment of portal hypertension. This review will focus on these processes within the intrahepatic circulation, a circulatory bed whose study, that Dr Roberto Groszmann has pioneered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17975474     DOI: 10.1097/MCG.0b013e318150d0e1

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  9 in total

Review 1.  Portal vein thrombosis in cirrhosis: Controversies and latest developments.

Authors:  Damian J Harding; M Thamara P R Perera; Frederick Chen; Simon Olliff; Dhiraj Tripathi
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

Review 2.  Angiocrine signaling in the hepatic sinusoids in health and disease.

Authors:  Enis Kostallari; Vijay H Shah
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-06-10       Impact factor: 4.052

Review 3.  Portal vein thrombosis in cirrhosis.

Authors:  Kaiser Raja; Mathew Jacob; Sonal Asthana
Journal:  J Clin Exp Hepatol       Date:  2013-12-31

4.  Portal Vein Thrombosis in Patients With Cirrhosis Undergoing Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors, Warfarin Efficacy, and Clinical Outcomes.

Authors:  Wan Yue-Meng; Yu-Hua Li; Hua-Mei Wu; Jing Yang; Li-Hong Yang; Ying Xu
Journal:  Clin Appl Thromb Hemost       Date:  2017-01-23       Impact factor: 2.389

5.  Acute Portal Vein Thrombosis Predicts Concomitant Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients.

Authors:  Tawfik Khoury; Muhammad Massarwa; Wadi Hazou; Saleh Daher; David Hakimian; Ariel A Benson; Toni Ashqar; Mahmud Mahamid; Shaul Yaari
Journal:  J Gastrointest Cancer       Date:  2019-12

6.  Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation.

Authors:  Barbara Renga; Andrea Mencarelli; Marco Migliorati; Eleonora Distrutti; Stefano Fiorucci
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

7.  Management of Chronic Portal Vein Thrombosis in a Cirrhotic Patient With Pancytopenia and Grade II Esophageal Varices.

Authors:  Ahmed Ali Aziz; Daoyu Yang; Muhammad Naeem; Donald Christmas
Journal:  Cureus       Date:  2022-01-12

8.  Selective gene expression profiling contributes to a better understanding of the molecular pathways underlying the histological changes observed after RHMVL.

Authors:  Janine Arlt; Sebastian Vlaic; Ronny Feuer; Maria Thomas; Utz Settmacher; Uta Dahmen; Olaf Dirsch
Journal:  BMC Med Genomics       Date:  2022-10-07       Impact factor: 3.622

9.  Role of estrogen receptor β selective agonist in ameliorating portal hypertension in rats with CCl4-induced liver cirrhosis.

Authors:  Cheng-Gang Zhang; Bin Zhang; Wen-Sheng Deng; Ming Duan; Wei Chen; Zhi-Yong Wu
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.